Evaluation of vitamin A and E deficiency with severity of SARS-COV-2 disease: a case–control study

The Egyptian Journal of Bronchology

Table 1 Demographic and clinical data of the study population

	Group A	Group B	Group C	P value
Age (years)†	59.40 (± 13.04)	54.93 (± 15.70)	53.43 (± 12.63)	0.228
Sex*
Female	20 (66.7%)	16 (53.3%)	16 (53.3%)	0.483
Male	10 (33.3%)	14 (46.7%)	14 (46.7%)	0.483
Co-morbidities*
Yes	29 (96.7%)^a	23 (76.7%)^a	0 (0.0%)^b	< 0.001
No	1 (3.3%)^a	7 (23.3%)^a	30 (100.0%)^b	< 0.001
Immunosuppressive drugs*
Yes	11 (36.7%)^a	17 (56.7%)^a	0 (0.0%)^b	< 0.001
No	19 (63.3%)^a	13 (43.3%)^a	30 (100.0%)^b	< 0.001

^{a, b, c}Groups bearing same initials do not show statistical significant difference at P value < 0.05
^{a, b, c}Groups bearing different initials show statistical significant difference at P value < 0.05
P value < 0.05 is considered statistically significant
^†Data are presented as mean ± SD
^*Data are presented as number (%)